Corsonello Andrea, Pedone Claudio, Corica Francesco, Mazzei Bruno, Mussi Chiara, Di Iorio Angelo, Incalzi Raffaele Antonelli
Recenti Prog Med. 2006 Feb;97(2):90-3.
The high prevalence of multiple chronic disorders and polypharmacotherapy expose elderly patient to an increased risk of adverse drug reactions. Aging is associated with relevant morphological and functional changes in the kidney, with consequent changes in the pharmacokinetics of hydrosoluble drugs. Changes in renal function are not always clinically evident, and a concealed renal failure can lead to an increased risk of adverse drug reactions to hydrosoluble drugs. Targeting these at-risk patients could contribute to reduce the risk of adverse drug reactions with relevant cost saving.
多种慢性疾病和联合药物治疗的高发生率使老年患者面临药物不良反应风险增加的问题。衰老与肾脏相关的形态和功能变化有关,从而导致水溶性药物的药代动力学发生变化。肾功能的变化在临床上并不总是明显的,隐匿性肾衰竭会导致水溶性药物发生药物不良反应的风险增加。针对这些高危患者可能有助于降低药物不良反应的风险,并节省相关成本。